Event

Martin Wilkins

MD
Hammersmith Hospital;Imperial College London

Dee Gor

MD
Roche

Mark Toshner

MBChB
University of Cambridge

Louise Harlow

Bec
Papworth Hospital

Jules Hernandez-Sanchez

PhD
Papworth Hospital

Emily Knightbridge

BA
Papworth Hospital

Jay Suntharalingam

MD
Royal United Hospital

John Wort

PhD
Imperial College

David Kiely

MD
Royal Hallamshire Hopsital;Royal Hallamshire Hospital;Sheffield Teaching Hospitals NHS Trust

Paul A. Corris

MD
Freeman Hospital;Freeman Hospital, University of Newcastle

A. Colin Church

MD
Golden Jubilee Hospital;Scottish Pulmonary Vascular Unit

Gerry Coghlan

MBBS
Royal Free Hosp;Royal Free Hospital, University College London

Nicholas W. Morrell

MD
Addenbrookes Hosp;Addenbrookes Hospital;University of Cambridge

Sean P. Gaine

MD, PhD
Mater Misericordiae Hosp;Mater Misericordiae Hospital;Mater Misericordiae University Hospital;Mater University Hospital

Simon Gibbs

MD
Hammersmith Hospital;Imperial College London, National Heart and Lung Institute

Transform-UK: A Phase 2 Trial of Tocilizumab in Pulmonary Arterial Hypertension